drugset / Trial / NCT01134328

Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model

NCT01134328

Phase 2 Completed 83 enrolled Aciex Therapeutics, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of AC-150 compared to vehicle and its components in the prevention of the signs and symptoms of allergic conjunctivitis in Enviro-CAC™ Model.

Timeline

Start
2010-05
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetirizine Other / unclassified 0.1 % Topical
Comparator Fluticasone Other / unclassified 0.005 % Topical

Indications